Fibroblast Specific Inhibition of LOXL2 and TGFbeta1 Signaling in Patients With Pulmonary Fibrosis.
Clinical trial NCT03928847 · COMPLETED
Trial details
- NCT number
- NCT03928847
- Sponsor
- Hal Chapman
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-01
- Primary completion
- 2019-05-31
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.